Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Breast cancer treatment Arimidex granted new indication for postmenopausal women
August 11th, 2005
AstraZeneca announced that Arimidex (anastrozole) has been granted a new indication from the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, which has acted as the reference member state for the European mutual recognition variation procedure leading to further approvals in five other European countries - Austria, Germany, Italy, Portugal and Spain. The new indication - Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer - will mean that more postmenopausal women whose breast cancer is fueled by the hormone, oestrogen - about 75% of all postmenopausal cases - are now eligible to receive...
Source: Women's Health Weekly (2005-08-11)
|
